Back to search
FDAFDA · Food and drugs·Recall number D-1244-2020

Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 grams (NDC 63275-9900-5), c) 25 grams (NDC 63275-9900-4), Distributed by B&B Pharmaceuticals, Inc. 800-499-3100

Published April 22, 2020 · Recall initiated: April 14, 2020

Summary

FDA records drug Class II recall D-1244-2020, published April 22, 2020 and initiated April 14, 2020. Recalling firm: B & B Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 3,825 grams; Lot: Lot #: 18K26-BB02-PR00553, Reassay 10/09/2023 Product # 700365, 700362 & 700363. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
B & B Pharmaceuticals, Inc.
Distributor
USA Nationwide
Lot
Lot #: 18K26-BB02-PR00553, Reassay 10/09/2023 Product # 700365, 700362 & 700363
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 grams (NDC 63275-9900-5), c) 25 grams (NDC 63275-9900-4), Distributed by B&B Pharmaceuticals, Inc. 800-499-3100 recalled?

Yes. FDA published recall D-1244-2020 on April 22, 2020. Reported hazard: cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.

What should I do if I have this product?

Voluntary: Firm initiated · Letter